The rationale and design of reduction of uncontrolled hypertension by Remote Monitoring and Telemedicine (REMOTE) study

References

• Staessen JA, Kuznetsova T, Stolarz K. Hypertension prevalence and stroke mortality across populations. JAMA. 2003;289:2420–2422.
   PubMed Web of Science ®Google Scholar
• Weinehall L, Ohgren B, Persson M, et al. High remaining risk in poorly treated hypertension: the ‘rule of halves’ still exists. J Hypertens. 2002;20:2081–2088.
   PubMed Web of Science ®Google Scholar
• Shimamoto K, Ando K, Fujita T, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res. 2014;37:253–390.
   PubMed Web of Science ®Google Scholar
• Chobanian AV. Shattuck Lecture. The hypertension paradox-more uncontrolled disease despite improved therapy. N Engl J Med. 2009;361:878–887.
   PubMed Web of Science ®Google Scholar
• Bosworth HB, Powers BJ, Olsen MK, et al. Home blood pressure management and improved blood pressure control: results from a randomized controlled trial. Arch Intern Med. 2011;171:1173–1180.
   PubMedGoogle Scholar
• Kim YN, Shin DG, Park S, et al. Randomized clinical trial to assess the effectiveness of remote patient monitoring and physician care in reducing office blood pressure. Hypertens Res. 2015;38:491–497.
   PubMed Web of Science ®Google Scholar
• Burnier M. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. Am J Hypertens. 2006;19:1190–1196.
   PubMed Web of Science ®Google Scholar
• Pickering TG. Home blood pressure monitoring: a new standard method for monitoring hypertension control in treated patients. Nat Clin Pract Cardiovasc Med. 2008;5:762–763.
   PubMedGoogle Scholar
• Bonafini S, Fava C. Home blood pressure measurements: advantages and disadvantages compared to office and ambulatory monitoring. Blood Press. 2015;24:325–332.
   PubMed Web of Science ®Google Scholar
• Asayama K, Ohkubo T, Metoki H, et al. Cardiovascular outcomes in the first trial of antihypertensive therapy guided by self-measured home blood pressure. Hypertens Res. 2012;35:1102–1110.
   PubMed Web of Science ®Google Scholar
• McManus RJ, Mant J, Bray EP, et al. Telemonitoring and self-management in the control of hypertension (TASMINH2): a randomised controlled trial. Lancet. 2010;376:163–172.
   PubMed Web of Science ®Google Scholar
• McManus RJ, Mant J, Haque MS, et al. Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: the TASMIN-SR randomized clinical trial. JAMA. 2014;312:799–808.
   PubMed Web of Science ®Google Scholar
• Asche SE, O’Connor PJ, Dehmer SP, et al. Patient characteristics associated with greater blood pressure control in a randomized trial of home blood pressure telemonitoring and pharmacist management. J Am Soc Hypertens. 2016;10:873–880.
   PubMed Web of Science ®Google Scholar
• Pawloski PA, Asche SE, Trower NK, et al. A substudy evaluating treatment intensification on medication adherence among hypertensive patients receiving home blood pressure telemonitoring and pharmacist management. J Clin Pharm Ther. 2016;41:493–498.
   PubMed Web of Science ®Google Scholar
• Margolis KL, Asche SE, Bergdall AR, et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA. 2013;310:46–56.
   PubMed Web of Science ®Google Scholar
• Lee CJ, Park S. The role of home blood pressure telemonitoring for blood pressure control. Pulse (Basel). 2016;4:78–84.
   PubMedGoogle Scholar
• Omboni S, Gazzola T, Carabelli G, et al. Clinical usefulness and cost effectiveness of home blood pressure telemonitoring: meta-analysis of randomized controlled studies. J Hypertens. 2013;31:455–468.
   PubMed Web of Science ®Google Scholar
• Tani S, Asayama K, Oiwa K, et al. The effects of increasing calcium channel blocker dose vs. adding a diuretic to treatment regimens for patients with uncontrolled hypertension. Hypertens Res. 2017;40:892–898.
   PubMed Web of Science ®Google Scholar
• Kario K, Tomitani N, Kanegae H, et al. Comparative effects of an angiotensin ii receptor blocker (ARB)/diuretic vs. ARB/calcium-channel blocker combination on uncontrolled nocturnal hypertension evaluated by information and communication technology-based nocturnal home blood pressure monitoring: the NOCTURNE study. Circ J. 2017;81:948–957.
   PubMed Web of Science ®Google Scholar
• El Assaad MA, Topouchian JA, Darne BM, et al. Validation of the Omron HEM-907 device for blood pressure measurement. Blood Press Monit. 2002;7:237–241.
   PubMed Web of Science ®Google Scholar
• Takahashi H, Yoshika M, Yokoi T. Validation of two automatic devices: omron HEM-7252G-HP and Omron HEM-7251G for self-measurement of blood pressure according to the European Society of Hypertension International Protocol revision 2010. Blood Press Monit. 2015;20:286–290.
   PubMed Web of Science ®Google Scholar
• Shiroiwa T, Fukuda T, Ikeda S, et al. Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D. Qual Life Res. 2016;25:707–719.
   PubMed Web of Science ®Google Scholar
• Morisky DE, Ang A, Krousel-Wood M, et al. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertension. 2008;10:348–354.
   PubMed Web of Science ®Google Scholar
• Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358:1887–1898.
   PubMed Web of Science ®Google Scholar
• Haller H, Ito S, Izzo JL Jr, et al. Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes. N Engl J Med. 2011;364:907–917.
   PubMed Web of Science ®Google Scholar
• Hong SH, Wang J, Tak S. A patient-centric goal in time to blood pressure control from drug therapy initiation. Clinical and Translational Science. 2013;6:7–12.
   PubMed Web of Science ®Google Scholar
• Weir MR, Levy D, Crikelair N, et al. Time to achieve blood-pressure goal: influence of dose of valsartan monotherapy and valsartan and hydrochlorothiazide combination therapy. Am J Hypertens. 2007;20:807–815.
   PubMed Web of Science ®Google Scholar
• Kerfoot BP, Turchin A, Breydo E, et al. An online spaced-education game among clinicians improves their patients’ time to blood pressure control: a randomized controlled trial. Circ Cardiovasc Qual Outcomes. 2014;7:468–474.
   PubMed Web of Science ®Google Scholar
• Weber MA, Julius S, Kjeldsen SE, et al. Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial. Lancet. 2004;363:2049–2051.
   PubMed Web of Science ®Google Scholar
• Staessen JA, Thijisq L, Fagard R, et al. Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial. J Hypertens. 2004;22:847–857.
   PubMed Web of Science ®Google Scholar
• Basile JN, Chrysant S. The importance of early antihypertensive efficacy: the role of angiotensin II receptor blocker therapy. J Hum Hypertens. 2006;20:169–175.
   PubMed Web of Science ®Google Scholar
• Caro JJ, Speckman JL, Salas M, et al. Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data. CMAJ. 1999;160:41–46.
   PubMed Web of Science ®Google Scholar
• Neutel JM, Smith DH. Improving patient compliance: a major goal in the management of hypertension. J Clin Hypertens (Greenwich). 2003;5:127–132.
   PubMedGoogle Scholar
• Nash DT, Crikelair N, Zappe D. Achieving BP goals with valsartan and HCTZ alone and in combination: pooled analysis of two randomized, double-blind, placebo-controlled studies. Curr Med Res Opin. 2008;24:2617–2626.
   PubMed Web of Science ®Google Scholar
• Weir S, Juhasz A, Puelles J, et al. Relationship between initial therapy and blood pressure control for high-risk hypertension patients in the UK: a retrospective cohort study from the THIN general practice database. BMJ Open. 2017;7:e015527.
   PubMed Web of Science ®Google Scholar
• Yatabe MS, Iwahori T, Watanabe A, et al. Urinary sodium-to-potassium ratio tracks the changes in salt intake during an experimental feeding study using standardized low-salt and high-salt meals among healthy Japanese volunteers. Nutrients. 2017;9:E951.
   PubMed Web of Science ®Google Scholar